Van Hulzen Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31
| Closed | -$1.12K | – | 1007 |
|
|
2024
Q4 | $1.12K | Buy |
+31
| New | +$1.12K | ﹤0.01% | 1013 |
|
|
2020
Q1 | – | Sell |
-14,813
| Closed | -$351K | – | 298 |
|
|
2019
Q4 | $351K | Buy |
14,813
+416
| +3% | +$9.86K | 0.07% | 198 |
|
|
2019
Q3 | $396K | Sell |
14,397
-1,734
| -11% | -$47.7K | 0.08% | 171 |
|
|
2019
Q2 | $534K | Buy |
16,131
+1,972
| +14% | +$65.3K | 0.12% | 124 |
|
|
2019
Q1 | $496K | Buy |
14,159
+960
| +7% | +$33.6K | 0.13% | 111 |
|
|
2018
Q4 | $438K | Buy |
13,199
+1,789
| +16% | +$59.4K | 0.13% | 122 |
|
|
2018
Q3 | $574K | Buy |
11,410
+5,275
| +86% | +$265K | 0.15% | 109 |
|
|
2018
Q2 | $367K | Buy |
+6,135
| New | +$367K | 0.11% | 126 |
|